POZEN Inc. (POZN) Profile

Profile for POZEN Inc.  (POZN) 
$ 4.42   -0.15 (-3.28%) Volume: 50.69 k 4:00 PM EST Feb 10, 2012
Business Description:
POZEN Inc. is a pharmaceutical company, which is focused on developing products which could provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.
Address: 1414 Raleigh Road, Suite 400, Chapel Hill, NC, 27517
Telephone: (919) 913-1030 Website: www.pozen.com
Facsimile: (919) 913-1039 Email: sbonestell@pozen.com
Details
CEO: Dr. John R. Plachetka,Pharm.D.
Employees: 29 Market Cap: 132.23 m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified
Indices: Drug Manufacturers - Other
Industry Classifications
Sector: Healthcare CIK: 0001059790
Industry: Drugs
Sub-Industry:    Drug Manufacturers - Other
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)   

Tags for POZEN Inc.

Research stocks or mutual funds related to POZEN Inc. by keywords or tags. Find companies that have a similar focus to POZN. The keywords below have been associated to POZN by either user submission or electronic means.

pharmaceutical sales data pharmaceutical articles biotech research clinical trial enrollment clinical research trial pharmaceutical branding pharmaceutical industry strategy pharmaceutical publication pharmaceutical market generic pharmaceutical pharmaceutical investment pharmaceutical automation niche pharmaceutical pharmaceutical specialties jobs in pharmaceutical pharmaceutical training pharmaceutical patents medical product development pharmaceutical research and development biotech jobs pharmaceutical supplies pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing migraine treatment corporate governance pharmaceutical tank pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company kv pharmaceutical company corporate governance issues pharmaceutical executives clinical research corporate governance ratings pharmaceutical ingredients pharmaceutical cro pharma companies pharma consulting active pharmaceutical ingredients good corporate governance pharmaceutical sales pfizer paid clinical trial pharma fda clinical trial pharmaceutical distributors biotech corporation pharmaceutical development